Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
The results of a prospective epidemiological analysis of the OsteoPerio (Osteoporosis and Periodontal Disease) study were recently reported in the Journal of the American Heart Association. In a fairly large cohort of over 1200 postmenopausal women (aged 53 to 81 at the outset of the study), the composition of the microbiome in the subgingival plaque was determined at baseline, and the incidence of physician-diagnosed hypertension was monitored over a mean follow-up of 10.4 years.
In this prospective and longitudinal analysis, over half of the women without hypertension at the beginning developed it by the end of the study period. Fifteen bacterial species present at baseline were significantly associated with the risk of developing hypertension; 10 species were associated with a 10-16% increase in risk (e.g., Streptococcus anginosus, Streptococcus salivarius, etc.), and 5 were associated with a 9-18% reduction in risk, (including Neisseria subflava, Aggregatibacter segnis, etc.), and these associations remained even after fully adjusted analysis (in 13/15 species).
This study appears to be the first prospective analysis linking specific bacterial species to the development of hypertension. Although mechanisms were not included in this analysis, one possibility suggested by the authors is that the presence of species which possess nitrate-reducing capacities may increase the available nitric oxide (NO) levels, leading to a reduction in blood pressure. They note that mammalian cells lack this ability, and thus we are dependent on microbial action to provide NO through this pathway. Other distinct mechanisms likely also play a role, such as a direct acceleration of atherosclerosis by certain species. This study supports the growing awareness of the relationship between the microbiome and blood pressure regulation, raising the hope that modulation of the oral microbiome may help prevent incident hypertension.
Submit this form and you'll receive our latest news and updates.
BMC Microbiology recently published a meta-analysis of metagenomic sequencing data from obese and non-obese participants...
Learn moreResults of a prospective and longitudinal study conducted among schoolchildren were recently published in Allergology In...
Learn moreResults of a small human clinical trial recently published in NPJ Biofilms and Microbiomes indicate that short-term use ...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment